The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

The antihistamine didn’t control the eczema. Sidbury R, Davis DM, et al. “Guidelines of care for the management of atopic dermatitis, Part 3: Guidelines of care for the management and treatment of ...

to twice-daily azelastine (an intranasal antihistamine), fluticasone propionate, the combination of the two, or placebo for 2 weeks during the allergy season; all treatments were administered as ...

CRAIG T. KOJIMA / NOV. 6 The judge instructed jurors Wednesday that they were allowed to find babysitter Dixie Denise Villa ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...

The state and the defense presented their final witnesses Tuesday in the manslaughter trial of Dixie Denise Villa, accused of giving a fatal dose of diphenhydramine, the antihistamine found in ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

Loratadine is approved for younger patients -- those as young as 2 years -- while desloratadine has thus far been tested and approved only for patients 12 years and older. Relief of the nasal and ...